OpenAlex
PricingAboutJobs
Log inGet started
Work

Phase II trial of paclitaxel and cisplatin in women with advanced breast cancer: an active regimen with limiting neurotoxicity.

HTML

Year: 1996
Type: article
Study design: Clinical Trial
Source: Journal of Clinical Oncology
DOI: 10.1200/jco.1996.14.7.1993
Authors: C Wasserheit, A Frazein, R Oratz, J Sorich, A Downey, H Hochster, A Chachoua, J Wernz, A Zeleniuch-Jacquotte, R Blum, J Speyer
Institutions: NYU Langone Health, New York University
Language: English

Topic: Cancer Treatment and Pharmacology
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: paclitaxel, cisplatin, advanced breast cancer, combination chemotherapy, first-line chemotherapy, neurotoxicity, neutropenia, objective response rate, stage III breast cancer, metastatic breast cancer, granulocyte colony-stimulating factor, treatment toxicity, breast cancer patients, duration of response, toxic death
SDG: Good health and well-being

Open Access status: closed

Funders: National Cancer Institute, National Center for Research Resources
Awards: General Clinical Research Center, Cancer Center Support Grant
OpenAlex ID: W2252617423
FWCI: 4.248
Cites: 14
Cited by: 93
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security